Athenex, Inc. (ATNX): Price and Financial Metrics
Athenex, Inc. (ATNX)
Today's Latest Price: $15.42 USD
0.23 (1.48%)
Updated Nov 21 6:55pm
Add ATNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ATNX Stock Summary
- Athenex Inc's stock had its IPO on June 14, 2017, making it an older stock than merely 6.9% of US equities in our set.
- With a price/sales ratio of 10.19, Athenex Inc has a higher such ratio than 89.66% of stocks in our set.
- With a year-over-year growth in debt of 4,018.08%, Athenex Inc's debt growth rate surpasses 98.79% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Athenex Inc are XON, ADAP, FOLD, ERYP, and SYNA.
- ATNX's SEC filings can be seen here. And to visit Athenex Inc's official web site, go to www.athenex.com.
ATNX Daily Price Range
ATNX 52-Week Price Range
ATNX Stock Price Chart More Charts
ATNX Price/Volume Stats
| Current price | $15.42 |
| Prev. close | $15.19 |
| Day low | $15.04 |
| Day high | $15.57 |
| 50-day MA | $12.10 |
| 200-day MA | $13.99 |
| 52-week high | $21.11 |
| 52-week low | $8.82 |
| Volume | 851,400 |
| Avg. volume | 610,847 |
| Dividend yield | N/A |
| Market Cap | 1.20B |
Athenex, Inc. (ATNX) Company Bio
Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.
Top Stories View All
Best & Worst Performing Stock Industries for November 21, 2019
Best & Worst Performing Small Cap Stocks for November 21, 2019
Best & Worst Performing Mid Cap Stocks for November 21, 2019
Best & Worst Performing Large Cap Stocks for November 21, 2019
Best & Worst Performing Mega Cap Stocks for November 21, 2019
View All Top Stories
Loading social stream, please wait...